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Abstract
Background: Nikkomycins are a group of peptidyl nucleoside antibiotics and act as potent
inhibitors of chitin synthases in fungi and insects. Nikkomycin X and Z are the main components
produced by Streptomyces ansochromogenes. Of them, nikkomycin Z is a promising antifungal agent
with clinical significance. Since highly structural similarities between nikkomycin Z and X, separation
of nikkomycin Z from the culture medium of S. ansochromogenes is difficult. Thus, generating a
nikkomycin Z selectively producing strain is vital to scale up the nikkomycin Z yields for clinical
trials.
Results: A nikkomycin Z producing strain (sanPDM) was constructed by blocking the imidazolone
biosynthetic pathway of nikkomycin X via genetic manipulation and yielded 300 mg/L nikkomycin
Z and abolished the nikkomycin X production. To further increase the yield of nikkomycin Z, the
effects of different precursors on its production were investigated. Precursors of nucleoside
moiety (uracil or uridine) had a stimulatory effect on nikkomycin Z production while precursors of
peptidyl moiety (L-lysine and L-glutamate) had no effect. sanPDM produced the maximum yields of
nikkomycin Z (800 mg/L) in the presence of uracil at the concentration of 2 g/L and it was
approximately 2.6-fold higher than that of the parent strain.
Conclusion: A high nikkomycin Z selectively producing was obtained by genetic manipulation
combined with precursors feeding. The strategy presented here might be applicable in other
bacteria to selectively produce targeted antibiotics.
Background
Nikkomycins, a group of peptidyl nucleoside antibiotics
produced by Streptomyces ansochromogenes [1] and Strepto-
myces tendae [2], are potent competitive inhibitors of chi-
tin synthase. These antibiotics are structurally similar to
UDP-N-acetylglucosamine which is the natural substrate
of chitin synthase. So they can inhibit the growth of
insects, acarids, yeasts, and filamentous fungi [3]. Nikko-
mycin X and Z, main components produced by both S.
ansochromogenes and S. tendae, are the most active struc-
Published: 23 November 2009
Microbial Cell Factories 2009, 8:61 doi:10.1186/1475-2859-8-61
Received: 24 September 2009
Accepted: 23 November 2009
This article is available from: http://www.microbialcellfactories.com/content/8/1/61
© 2009 Liao et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7
(page number not for citation purposes)
Microbial Cell Factories 2009, 8:61 http://www.microbialcellfactories.com/content/8/1/61tures (Fig. 1). They are composed of hydoxypyridyl-
homethreonine (nikkomycin D) and a 5-aminohexuronic
acid N-glucosidically bound to uracil in nikkomycin Z or
to 4-formyl-4-imidazolin-2-one (imidazolone) in nikko-
mycin X. The corresponding nucleoside moieties are des-
ignated as nikkomycin Cz and Cx. Nikkomycin I and J,
produced as minor components by S. tendae but not by S.
ansochromogenes, are structurally analogous to nikkomycin
X and nikkomycin Z and contain glutamic acid peptidi-
cally bound to the 6'-carboxyl group of aminohexuronic
acid [4]. In the past few years, particular attention has
been drawn to nikkomycin Z for its significant activity
against the highly chitinous, pathogenic, dimorphic fungi
Coccidioides immitis and Blastomyces dermatitidis and phase
I/II clinical research of nikkomycin Z as an orphan prod-
uct for treatment of occiciodomycosis is undergoing [5].
Meanwhile, nikkomycin Z has synergetic effect with
azoles and echinocandins against Candida albicas and
Aspergillus fumigatus [6-8]
Separation of nikkomycin Z from the culture medium is
difficult due to the highly structural similarity among nik-
komycins. This is much more complicated by its iosmer
nikkomycin X. Thus, the abolishment of nikkomycin X, I
and J production is crucial for scaling up nikkomycin Z
yields for clinical trials. Studies such as strain improve-
ment, optimization of the production medium and fer-
mentation process, have significantly increased the yield
of nikkomycins, but strains selectively producing nikko-
mycin Z remain unavailable [9]. Recently, considerable
progresses have been made in understanding nikkomycin
biosynthesis in S. ansochromogenes and S. tendae. Nikko-
mycin biosynthetic cluster has been identified in both
strains and subsequent biochemical characterizations
have elucidated the functions of some genes. Among
them, sanO, sanQ, sanR and SanX were involved in bio-
synthesis of nikkomycin Cx and Cz (Fig. 2) [10-12]. Gene
disruption of sanO or sanQ resulted in the blocking of nik-
komycin X biosynthesis in S. ansochromogenes 7100, but
had no effect on the production of nikkomycin Z. These
studies raised the possibility that the blocking of nikko-
mycin X biosynthesis by genetic manipulation in S. anso-
chromogenes might generate a dedicated nikkomycin Z
producing strain, since nikkomycin I and J were not pro-
duced by S. ansochromogenes.
In this paper, a strain which produced high-level of nikko-
myicns obtained by traditional strain improvement was
chosen as the parent strain for genetic manipulation. A
nikkomycin Z selectively producing strain was generated
by blocking the imidazolone biosynthetic pathway of nik-
komycin X. The subsequent uracil feeding further
enhanced the yield of nikkomycin Z.
Results
Construction of the nikkomycin Z selectively producing 
strain
To obtain an ideal strain only producing nikkomycin Z,
the disruption of sanP in S. ansochromogenes TH322 was
performed (Fig. 3A). sanP is an homologue of nikP2 of S.
tendae (sharing 95% identity), which is vital for the bio-
synthesis of imidazolone that is an unique part of nikko-
mycin X [13]. The resulting sanP disruption mutant
(sanPDM) was passed through five generations in the
absence of antibiotic pressure. The progeny still conferred
kanamycin resistance, indicating the resulting sanPDM
was genetically stable.
S. ansochromogenes sanPDM produced almost the same
amounts of nikkomycin Z (300 mg/L) as TH322 (Fig. 3B),
while no nikkomycin X was produced by sanPDM. Bio-
mass of sanPDM was approximately equal to that of
TH322 (Fig. 4A).
In S. ansochromogenes, sanP is located in one of the oper-
ons [1]. To exclude the potential polar effect of sanP dis-
ruption on the loss of nikkomycin X, the complementary
plasmid pIM229::sanP constructed with wild type sanP
under the control of the ermE* promoter was introduced
into the sanPDM. The introduction of pIM229::sanP into
sanPDM restored nikkomycin X production. HPLC analy-
sis and bioassay showed that the amounts of nikkomycins
produced by the complemented strain were almost the
same as those produced by the parent strain (Fig. 3B). The
Chemical structures of nikkomycin X (A) and Z (B), the main componen s produced by Streptomyces ansochromogen s TH322Figure 1
Chemical structures of nikkomycin X (A) and Z (B), 
the main components produced by Streptomyces ans-
ochromogenes TH322.Page 2 of 7
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that sanP was a key determinant in nikkomycin X biosyn-
thesis and disruption of sanP did not affect the production
of nikkomycin Z.
Effect of precursor of nucleoside moiety on nikkomycin Z 
production
To further increase the yield of nikkomycin Z, the effects
of different precursors on its production were investi-
gated. Recent studies revealed that UMP was the direct
precursor for the biosynthesis of the nucleoside moiety of
nikkomycin Z [14] and UMP could be synthesized from
uracil or uridine through salvage pathway. So, the effect of
supplementation of varying concentration (1 g/L-3 g/L) of
uracil on nikkomycin production was measured in S. ans-
ochromogenes TH322 and sanPDM. As shown in Fig. 4B,
uracil had a stimulatory effect on nikkomycin Z produc-
tion in both strains and uracil supplementation led to
much more nikkomycin Z production in sanPDM than
that in TH322 at all concentrations tested in the study.
Addition of uracil (1 g/L to 2 g/L) resulted in increased
nikkomycin Z production from 450 mg/L to 800 mg/L in
sanPDM or increased from 375 mg/L to 630 mg/L in
TH322, whereas nikkomycin X production was decreased
from 195 mg/L to 96 mg/L in TH322 (Fig. 4C). The
change of biomass was observed in both strains. Addition
of uracil (2 g/L) in the culture medium resulted in reduced
the biomass by approximate 40% compared to that of the
control (Fig. 4A). Addition of more uracil (3 g/L) resulted
in significant inhibition of cell growth and reduced the
final yield of nikkomycins in both strains. These results
demonstrated that addition higher concentration of uracil
might inhibit cell growth.
To determine uracil consumption, uracil residue in the
culture medium after fermentation was measured. As
shown in Table 1, uracil could be hardly detected when
uracil was fed at the concentration of 1.5 g/L, while 0. 484
g/L uracil left when 2 g/L uracil was fed. These results indi-
cated that only 1.5 g/L uracil can be utilized during the fer-
Biosythetic pathway of nucleoside moiety of nikkomycin in S. ansochromogenesF gure 2
Biosythetic pathway of nucleoside moiety of nikkomycin in S. ansochromogenes. Some biosynthetic steps were omit-
ted. SanO, L-His-specific didomain NRPS; SanP, type II thioesterase; SanQ, heme hdyroxylase; SanR, uracil phosphoribosyl-
transferase; SanS, enolpyruvyl transferase; Upp, uracilmphosphoribosyltransferase; PRPP, 5-phosphoribosyl-alpha-1-
diphosphate; PEP, phosphoenolpyruvate;. Disruption of sanP resulted in blocking the synthesis of β-OH-His.Page 3 of 7
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concentration of uracil (2 g/L) was used to achieve the
maximum production of nikkomycin Z.
Similar studies were carried out to determine the effect of
uridine supplementation on nikkomycin Z production.
Addition of uridine (0.5 g/L to 2 g/L) resulted in enhanc-
ing nikkomycin Z production from 320 mg/L to 400 mg/
L without detectable effect on the biomass (data not
shown). Thus, uridine exerted a less stimulatory effect
than uracil on nikkomycin Z production.
Insertional inactivation of sanP and analysis of nikkomycin productionFigure 3
Insertional inactivation of sanP and analysis of nikkomycin production. (A) Diagram of sanP gene disruption in S. ans-
ochromogenes TH322. A kanamycin antibiotic resistance cassette was inserted into the BamHI site of sanP. (B) Bioassay and 
HPLC analysis of nikkomycin production. X, nikkomycin X; Z, nikkomycin Z; 1, culture filtrates from TH322; 2, culture filtrates 
from sanPDM; 3, culture filtrates from the complementary strain; 4, culture filtrates from sanPDM feeding with 2 g/L uracil. 
The strains were inoculated in liquid SP medium for 144 h.
Effect of uracil on biomass and nikkomycin productionFigure 4
Effect of uracil on biomass and nikkomycin production. (A) Effect of uracil on the biomass of S. ansochromogenes TH322 
and sanPDM; (B) Effect of uracil on the nikkomycin Z production in S. ansochromogenes TH322 and sanPDM; (C) Effect of uracil 
on the nikkomycin X production in S. ansochromogenes TH322.Page 4 of 7
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production
Precursor feeding and biochemical studies have shown
that L-glutamate and L-lysine are precursors for biosyn-
thesis of peptidyl moiety of nikkomycin Z [15,16].
L-lysine and L-glutamate (0.5, 1 and 2 g/L) were added
separately to the culture medium fed with 2 g/L uracil in
order to study their influences on the nikkomycin Z pro-
duction in S. ansochromogenes sanPDM. It was observed
that L-lysine (0.5 g/L to 1 g/L) had no remarkable effect on
the nikkomycin Z production and the biomass (Table 2).
Further increasing the concentration of lysine resulted in
decreased the yield of nikkomycin Z and inhibited the cell
growth. Similar results were obtained when L-glutamate
was added into the culture medium. As both L-lysine and
L-glutamate are needed to synthesize the peptidyl moiety,
the effect of supplementing L-lysine and L-glutamate in
culture medium on the yield of nikkomycin Z was studied
(Table 2). It was observed that there was no increase in
nikkomycin Z production with L-lysine and L-glutamate
feeding compared to that without supplementation.
These results together demonstrated that L-lysine and L-
glutamate might not be the limiting-factor of nikkomycin
Z production in the complex SP medium. So, the opti-
mum condition to obtain maximum productivity of nik-
komycin Z (800 mg/L) was culturing the sanPDM in the
presence of uracil at the concentration of 2 g/L
Discussion
Nikkomycin Z is a potential antifungal agent with clinical
significance. However, the presence of its isomer, nikko-
mycin X during fermentation interferes with the purifica-
tion of nikkomycin Z and increases the production cost.
Thus, we chose a nikkomycin high producing strain (S.
ansochromogenes TH322) to perform genetic manipulation
and obtained a nikkomycin Z selectively producing strain
(sanPDM). sanP encoded a type II thioesterase which
hydrolytically released SanO from β-OH-His-SanO to
form β-OH-His (Fig. 2). Disruption of it resulted in block-
ing the synthesis of β-OH-His and failed production of
nikkomycin Cx and nikkomycin X, whereas, disruption of
sanP did not affect nikkomycin Z production because
uracil, the base in nikkomycin Z, was biosynthesized via
de novo or salvage pathway. These results were mainly in
accordance with those studies in S. tendae [13]. Disrup-
tion of nikP2 almost abolished the nikkomycin X produc-
tion, while disruption of sanP in S. ansochromogenes
resulted in eliminating nikkomycin X production. Loss of
the nikkomycin X production in the fermentation would
significantly improve the recovery of nikkomycin Z during
large scale manufacturing process.
Feeding precursors have been proved to be a successful
strategy to increase the yield of targeted antibiotics, such
as feeding ornithine to enhance clavulanic acid produc-
tion in S. clavuligerus [17]. We found that addition of
uracil (2 g/L) increased production of nikkomycin Z by 2-
fold while suppressed nikkomycin X production by 85%
in TH322. A possible explanation to these results was that
UMP derived form uracil competed with imidazolone for
incorporation into core of nikkomycin. A similar study on
salinosporamide B in Salinispora tropica was verified, find-
ing that addition of butyric acid-the precursor of salino-
sporamide B to the culture medium resulted in increased
the production of salinosporamide B by approximately
3.2-fold while inhibited the production of salinospo-
ramide A by 26% [18].









0 300 ± 20 14.8 ± 2.2 ND
0.5 400 ± 15 13.4 ± 1.7 ND
1.0 480 ± 18 11.0 ± 2.2 ND
1.5 790 ± 23 9.5 ± 1.4 0.080 ± 0.020
2.0 800 ± 18 9.1 ± 1.0 0.484 ± 0.031
ND, not detected in culture medium
Table 2: Effect of L-lysine and L-glutamate on nikkomycin Z 
production in sanPDM in the presence of 2 g/L uracil




Control 785 ± 10 9.9 ± 1.9
L-lysine
0.5% 780 ± 16 10.2 ± 2.1
1% 700 ± 40 9.2 ± 1.3
2% 500 ± 9 5.3 ± 1.9
L-glutamate
0.5% 770 ± 30 9.7 ± 1.7
1% 720 ± 12 9.5 ± 2.1
2% 400 ± 23 4.8 ± 1.6
L-lysine+L-glutamate
0.5%+0.5% 750 ± 30 9.6 ± 1.5
1%+1% 740 ± 24 9.8 ± 2.0Page 5 of 7
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nikkomycin Z production, while its high concentration
(more than 2 g/L) significantly inhibited cell growth and
reduced the yield of nikkomycin Z. Our results were in
accordance with the reports of Krishna [19]. Uracil (2 g/L)
could improve the rifamycin SV production by 505 mg/L
in Amycolatopsis mediterranei MV35R, while higher concen-
tration inhibited both the cell growth and rifamycin SV
production. The reason why higher concentration of
uracil sharply inhibited the cell growth was still unclear.
Uridine had a slight effect on nikkomycin Z production.
Uracil salvage pathway had been identified in S. grieus and
S. coelicolor [20] and genes involving in uracil transport
(uracil permase) and transformation to UMP (uracil
phosphoribosyltransferase) were highly conserved in
Streptomyces. However, gene encoding uridine kinase that
converted uridine into UMP had not been found in Strep-
tomyces so far. So, we speculated that the stimulatory effect
of uridine on nikkomycin Z production may be due to the
partial degradation of uridine to uracil and uracil acted as
precursor to participate in nikkomycin Z biosynthesis.
Conclusion
Combining genetic manipulation with uracil feeding ena-
bled us to selectively enhance the yield of nikkomycin Z.
As nikkomycin Z could be recovered without additional
separation from other related components in sanPDM, it
would simplify the downstream purification process and
lower the production cost.
Methods
Strains, plasmids and culture conditions
Streptomyces ansochromogenes TH322, a high-level pro-
ducer of nikkomycins (300 mg/L nikkomycin Z and 600
mg/L nikkomycin X), was collected in our laboratory. S.
ansochromogenes sanPDM, the nikkomycin Z selectively
producing strain created in this study was deposited with
the China General Microbiological Culture Collection
Center (CGMCC) and assigned the accession number was
CGMCC-3086. Candida albicans CGMCC No 2.2086 was
used as indicator strain for nikkomycin bioassays.
Escherichia coli JM109 was used as host for cloning and
subcloning. E. coli ET12567 containing pUZ8002 was
used for conjugal transfer according to the established
protocol [21]. Streptomyces-E. coli shuttle plasmid
pKC1139 for gene disruption was provided by Prof. Keith
Chater (John Innes Center, Norwich, UK)
S. ansochromogenes TH322 was grown on mannitol/soya
(MS) medium at 28°C [21] for 6 days to form spores. For
genomic DNA isolation, the S. ansochromogenes TH322
and sanP disruption mutant (sanPDM) were grown in
YEME medium for 2 days. SP medium (3% mannitol, 1%
soluble starch, 0.5% soy peptone and 0.8% yeast extract,
pH 6.0) was used for nikkomycin production.
When necessary, antibiotics were used at the following
concentrations: apramycin, 10 μg ml-1 in YEME or MS for
S. ansochromogenes TH322, 100 μg ml-1 in LB for E. coli;
kanamycin, 10 μg ml-1 in YEME or MS for S. ansochromo-
genes TH322, 100 μg ml-1 in LB for E. coli.
Primers and PCR conditions
The oligonucletide primers used to amplify the sanP were
P1 (5'-GTGGCACCGCGACAGGCCG-3') and P2 (5'-
TCAACTCTCATCGGCTC-3'). P3 (5'-GCGGCCAGCTACT-
TCCGGGAC-3') and P4 (5'-GCAGAAAGGCCGAGCG-
CATGT-3') were used to check the sanP disruption
mutant. The PCR was performed using KOD (Toyobo,
Japan): an initial denaturation at 95°C for 4 min followed
by 30 cycles of amplification (95°C for 1 min, 62°C for
30 sec, and 68°C for 1 min) and additional 10 min at
68°C.
Construction of sanP disruption mutants
Disruption of sanP was performed by gene replacement
via homologous recombination. For this purpose, a 2.5 kb
PstI-SacI DNA fragment containing the complete sanP
sequence was inserted into the PstI-SacI site of pBluescript
II KS (-) to generate pBS::sanP. The kanamycin-resistance
gene (neo) was isolated from pUC119::neo after digestion
with BamHI and KpnI, blunted and inserted into the
blunted BamHI site of sanP in pBS::sanP to generate
pBS::sanP::neo. A 3.5 kb PstI-SacI fragment from
pBS::sanP::neo was inserted into the PstI-SacI site of
pIJ2925 to give pIJ2925::sanP::neo. The resulting plasmid
was then digested with BglII and the resulting 3.5 kb frag-
ment was inserted into the BamHI site of pKC1139 to gen-
erate pKC1139::sanP::neo.
The resulting plasmid pKC1139::sanP::neo was passed
through E. coli ET12567/pUZ8002 and then introduced
into S. ansochromogenes TH322 by conjugal transfer
according to the established techniques. The resulting
transformants were inoculated on MS plates to form
spores. Gray spores were harvested and spread on MM
plates containing kanamycin as the resistance selection.
After incubating at 42°C for 3 days, the colonies that con-
ferred kanamycin resistance (KanR) and apramycin sensi-
tivity (AprS) were selected and further confirmed as sanP
disruption mutatants by PCR using the sanPDM genomic
DNA as template.
Complementation of the sanP mutant
For complementation analysis, complete sanP DNA frag-
ment was amplified from S. ansochromogenes TH322
genomic DNA by PCR using P1 and P2 primers. The
amplified fragment was subsequently inserted into the
EcoRV site of pIM229 under the control of promoter of
ermE* [22]. The resulting recombinant plasmidPage 6 of 7
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attB site of sanP disruption mutant by conjugal transfer.
Fermentation of S. ansochromognes
Spores of S. anchromogenes TH322 or sanPDM were inoc-
ulated in YEME. The cultures were grown at 28°C on a
rotary shaker (220 rpm) for 48 h and used as seed cul-
tures. 1 ml (0.5% V/V) of seed culture was inoculated into
flasks containing 50 ml of SP medium, and then fer-
mented at 28°C on a rotary shaker (200 r.p.m) for 6 days.
Quantification of uracil in the culture filtrates
Uracil was analyzed according to the method of Gao [23]
by HPLC using a Zorbax SB-C18 reverse-phase column at
254 nm with a 0.5 ml min-1 flow rate at 25°C. The elution
profile was a linear gradient of 0%-20% solution B (A = 5
mM ammonium acetate; B = methanol) over 15 min. An
aliquot of 20 μL culture filtrates was injected for HPLC
analysis.
Bioassay and HPLC analysis of nikkomycins
The culture filtrates were harvested by centrifugation and
the supernatant was filtered through a Minipore mem-
brane (pore diameter 0.2 μm). Nikkomycin Z (Sigma, cat.
No. N8028) was used as standard. HPLC analysis and bio-
assay of nikkomycins against Candida albicans were per-
formed as described previously [24].
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